Advanced Oncotherapy (LSE:AVO) Interest Expense : £-5.77 Mil (TTM As of Jun. 2022)

View and export this data going back to 2006. Start your Free Trial

What is Advanced Oncotherapy Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Advanced Oncotherapy's interest expense for the six months ended in Jun. 2022 was £ -2.42 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2022 was £-5.77 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Advanced Oncotherapy's Operating Income for the six months ended in Jun. 2022 was £ -13.54 Mil. Advanced Oncotherapy's Interest Expense for the six months ended in Jun. 2022 was £ -2.42 Mil. Advanced Oncotherapy did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Advanced Oncotherapy Interest Expense Historical Data

The historical data trend for Advanced Oncotherapy's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advanced Oncotherapy Interest Expense Chart

Advanced Oncotherapy Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Interest Expense

Get a 7-Day Free Trial

-1.28

-0.08

-1.23

-4.17

-5.06

Advanced Oncotherapy Semi-Annual Data
	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22
Interest Expense	Get a 7-Day Free Trial															-2.40	-1.77	-1.71	-3.35	-2.42

Advanced Oncotherapy Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-5.77 Mil.

Advanced Oncotherapy (LSE:AVO) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Advanced Oncotherapy's Interest Expense for the six months ended in Jun. 2022 was £-2.42 Mil. Its Operating Income for the six months ended in Jun. 2022 was £-13.54 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Jun. 2022 was £45.32 Mil.

Advanced Oncotherapy's Interest Coverage for the quarter that ended in Jun. 2022 is calculated as

Advanced Oncotherapy did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Advanced Oncotherapy (LSE:AVO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Advanced Oncotherapy PLC (LSE:AVO) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

4 Tenterden Street, Third Floor, London, GBR, W1S 1TE

Website

https://www.avoplc.com

Advanced Oncotherapy PLC is active in the healthcare domain in the United Kingdom. As a medical care provider, its focus is to develop technologies to maximize the destructive effect of radiation on tumors whilst minimizing damage to healthy tissues. It develops an affordable proton-based radiotherapy system, using innovative and clinically effective technology, thereby contributing to curing critical unmet conditions. The company's only business segment is Proton Therapy.